Point-Of-Care Molecular Diagnostics Market Size And Forecast
According to Verified Market Research, the Global Point-Of-Care Molecular Diagnostics Market was valued at USD 1.76 Billion in 2018 and is projected to reach USD 4.61 Billion by 2026, growing at a CAGR of 12.53% from 2019 to 2026.
The latest survey on Global Point-Of-Care Molecular Diagnostics Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunities available and trend in Point-Of-Care Molecular Diagnostics Market. The report bridges the historical data from 2013 to 2018 and forecasted till 2026. The report aims to present the analysis of Global Point-Of-Care Molecular Diagnostics Market By Product Type, By Component, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities.
What Is Point-Of-Care Molecular Diagnostics?
Point-Of-Care (POC) molecular diagnostics are the tests that are performed at a site near to the patient. It can be done in a hospital, clinic, ambulance, field or physician's office. POC molecular diagnostics is fast and efficient and therefore reaches more patients. The test results are fast and thus ensures that timely treatment is offered to the patients. It also eliminates the follow-up visits of the patient. Molecular technologies are employed that tests the nucleic acid or the DNA of the patient for the detection of any pathogens, infections, tumors or abnormalities.
Global Point-Of-Care Molecular Diagnostics Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
More patients are preferring for Point-Of-Care (POC) molecular diagnosis. The market is anticipated to propel due to several advantages it has to offer such as - convenience, reduced patients' waiting time, fewer or no follow-ups, accurate test results, immediate planning for treatment, and improved healthcare delivery. Hospital visits become difficult for the geriatric population and rise in geriatric population is helping the market to grow. With such type of diagnosis, the spread of infectious diseases is also brought under control. Many hospitals and clinics are offering the option of POC molecular diagnosis, therefore driving the market forward. However, lack of awareness and poor progress in developing countries are the biggest restraints in the market.
Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Point-Of-Care Molecular Diagnostics Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.
Global Point-Of-Care Molecular Diagnostics Market Competitive Landscape
The "Global Point-Of-Care Molecular Diagnostics Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Novartis AG, Siemens Healthcare GmbH, Danaher Corporation, Bio-Rad Laboratories Inc., Bayer AG, Qiagen, Becton Dickinson Co., Alere Inc. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1 INTRODUCTION OF GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES
5.1 Overview
5.2 Assays and Kits
5.3 Instruments and Analyzers
5.4 Services and Software
5.5 Others
6 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
6.1 Overview
6.2 Oncology
6.3 Hepatitis
6.4 Hematology
6.5 Infectious Disease
6.6 Others
7 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 Overview
7.2 Polymerase Chain Reaction (PCR)
7.3 Genetic Sequencing
7.4 Microarray
7.5 Others
8 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USE
8.1 Overview
8.2 Decentralized Labs
8.3 Hospitals
8.4 Homecare
8.5 Others
9 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER
9.1 Overview
9.2 Hospitals
9.3 Diagnostic Centers
9.4 Academic and Research Institutes
9.5 Others
10 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.2 Middle East
11 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Ranking
11.3 Key Development Strategies
12 COMPANY PROFILES
12.1 Novartis AG
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Siemens Healthcare GmbH
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Danaher Corporation
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Bio-Rad Laboratories Inc.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Bayer AG
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Qiagen
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.7 Becton Dickinson Co.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.8 Alere Inc.
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
13 Appendix
13.1 Related Research
The Elderly Care Service Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
The Smart Elderly Care Cloud Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Elderly Care Aids Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/pla...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The Event Concession Point Of Sale Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Primary Care Subscription Model Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Patient Care Environment Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...